Insider Transactions in Q1 2025 at Biodesix Inc (BDSX)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 11
2025
|
Robin Harper Cowie CFO, Sec'y & Treasurer |
SELL
Open market or private sale
|
Direct |
24,664
-9.1%
|
$0
$0.92 P/Share
|
|
Feb 11
2025
|
Scott Hutton President & CEO |
SELL
Open market or private sale
|
Direct |
83,660
-10.65%
|
$0
$0.92 P/Share
|
|
Feb 11
2025
|
Kieran O'Kane Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
17,527
-12.04%
|
$0
$0.92 P/Share
|
|
Feb 11
2025
|
Gary Anthony Pestano Chief Development Officer |
SELL
Open market or private sale
|
Direct |
16,748
-9.69%
|
$0
$0.92 P/Share
|
|
Feb 11
2025
|
Chris Vazquez Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,630
-17.08%
|
$0
$0.92 P/Share
|
|
Feb 10
2025
|
Robin Harper Cowie CFO, Sec'y & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
67,788
+20.0%
|
-
|
|
Feb 10
2025
|
Scott Hutton President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
252,628
+24.33%
|
-
|
|
Feb 10
2025
|
Kieran O'Kane Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
48,118
+24.84%
|
-
|
|
Feb 10
2025
|
Gary Anthony Pestano Chief Development Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
45,729
+20.93%
|
-
|
|
Feb 10
2025
|
Chris Vazquez Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,666
+31.26%
|
-
|